F-18-氟化钠PET/CT半定量指标对强直性脊柱炎患者治疗反应的预测价值
本研究纳入28例男性强直性脊柱炎患者,基于基线F-18-氟化钠PET/CT测量脊柱后部关节病灶与L5椎体本底的比值(LBR),随访中位4.5年。结果显示脊柱后部关节LBR与随访BASDAI评分呈正相关(r=0.394,P=0.042),提示其可能作为预测治疗反应的替代标志物。
要点
- 脊柱后部关节LBR与随访BASDAI正相关,r=0.394。
- LBR定义为病灶SUVmax除以L5椎体平均SUV。
- 基线PET/CT半定量指标可能预测AS治疗反应。
核心结论
- 在强直性脊柱炎患者中,基线PET/CT上脊柱后部关节的LBR可被认为是预测治疗反应的潜在替代标志物之一。
研究设计与样本
- 本研究为纳入28例男性强直性脊柱炎患者的影像学与临床随访研究,疾病活动度范围较宽。
- 采用基线F-18-氟化钠PET/CT,视觉评估三个区域异常骨代谢病灶:前部椎间盘椎体单元、椎体后部关节(颈椎、胸椎和腰椎小关节、肋椎关节和肋横突关节)及骶骨骶髂关节。
- 测量各区域病灶最高SUVmax,LBR定义为病灶SUVmax除以L5椎体平均SUV。
- 临床疾病活动度采用BASDAI评估,治疗反应基于随访BASDAI评分评价。
关键影像表现/征象
- 基线F-18-氟化钠PET/CT上可见前部椎间盘椎体单元、后部关节及骶髂关节的异常骨代谢病灶。
- 脊柱后部关节LBR与随访BASDAI评分呈显著正相关(r=0.394,P=0.042)。
诊断标准与关键数值
- LBR为半定量指标,定义为病灶SUVmax除以L5椎体平均SUV。
- 治疗反应基于随访BASDAI评分评价,BASDAI从基线中位6.6(范围1.0-9.5)降至随访中位2.0(范围0.6-8.1),P<0.001,BASDAI变化中位-3.4(范围-8.2-4.4)。
临床应用与阅片要点
- 阅片时可关注脊柱后部关节的异常骨代谢病灶并测量其SUVmax,按LBR公式计算半定量指标。
- 原文提示脊柱后部关节LBR可能作为预测治疗反应的潜在替代标志物之一。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: We aimed to investigate whether the lesion-to-background ratio (LBR) of the whole spinal column in ankylosing spondylitis (AS) patients based on baseline F-18-fluoride positron emission tomography/computed tomography (PET/CT) is associated with treatment response.
METHODS: Twenty-eight male patients with a wide range of disease activity were included in this study. Abnormal bone metabolic lesions on baseline F-18-fluoride PET/CT were visually assessed in three areas: anterior discovertebral units (DVUs) and posterior joints (cervical, thoracic, and lumbar facet joints, costovertebral joints, and costotransverse joints) of vertebrae and sacroiliac joints of the sacrum. The highest maximum standardized uptake value (SUVmax) of lesions within each area was measured. The LBR as a semi-quantitative index was defined as SUVmax of the lesion divided by mean SUV of the L5 vertebral body. Clinical disease activity was assessed using the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and treatment response was evaluated based on follow-up BASDAI score.
RESULTS: The median follow-up period was 4.5 years (range, 0.9-5.5). The BASDAI score significantly decreased from median 6.6 (range, 1.0-9.5) at baseline to 2.0 (range, 0.6-8.1) at follow-up (P < 0.001), and the median change in BASDAI score was -3.4 (range, -8.2-4.4). The LBR of posterior joints in the spinal column had a significant positive correlation with follow-up BASDAI score (r = 0.394, P = 0.042).
CONCLUSION: In patients with AS, the LBR of posterior joints of the spinal column on baseline PET/CT could be considered one of the potential surrogate markers for predicting treatment response.
引用
- Lee SJ, Kim JY, Choi YY, et al. Predictive value of semi-quantitative index from F-18-fluoride PET/CT for treatment response in patients with ankylosing spondylitis. Eur J Radiol. 2020. PMID: 32446125. doi:10.1016/j.ejrad.2020.109048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。